Your institution may have access to this item. Find your institution then sign in to continue.
Title
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.
Authors
Stehr, K; Cherry, J D; Heininger, U; Schmitt-Grohé, S; uberall, M; Laussucq, S; Eckhardt, T; Meyer, M; Engelhardt, R; Christenson, P
Abstract
The goal of the trial was to determine the efficacy of a multicomponent acellular pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and DT.